MUSTANG BIO INC (MBIO)
US62818Q2030 - Common Stock
Mustang Bio Receives Positive Listing Determination from Nasdaq
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial Preclinical data...
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024
MBIO stock results show that Mustang Bio beat analyst estimates for earnings per share the second quarter of 2024.
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mustang Bio (NASDAQ:MBIO) just reported results for the second quarter of 2024....
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
/CNW/ -- USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
/PRNewswire/ -- USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of...
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!
ACHR Stock Alert: Archer Aviation Strikes New Deal With Signature Aviation
Archer Aviation stock is down on Monday after the company alerted ACHR investors to a new MOU signed with Signature Aviation.
AAN Stock Alert: The Aaron’s Company Pops 33% on Take-Private Deal
The Aaron's Company stock is up on Monday after it announced a take-private deal that values AAN shares at $10.10 each.
Why Is Ovid Therapeutics (OVID) Stock Down 69% Today?
Ovid Therapeutics stock is down on Monday with heavy trading of OVID shares after the company reported a failed Phase3 clinical trial.
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
Mustang Bio stock is up on Monday with heavy trading of MBIO shares alongside its positive Phase 1/2 clinical trial data.